Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

643 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hepatocellular carcinoma treated with radical resection after endoscopic diagnosis of the extent of bile duct invasion: A case report.
Sato Y, Tadokoro T, Yamana H, Akai H, Takuma K, Fujita N, Nakahara M, Oura K, Fujita K, Tani J, Kamada H, Morishita A, Kobara H, Kagawa S, Haba R, Okano K, Masaki T. Sato Y, et al. Among authors: nakahara m. DEN Open. 2023 Jul 5;4(1):e265. doi: 10.1002/deo2.265. eCollection 2024 Apr. DEN Open. 2023. PMID: 37416500 Free PMC article.
Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
Samukawa E, Fujihara S, Oura K, Iwama H, Yamana Y, Tadokoro T, Chiyo T, Kobayashi K, Morishita A, Nakahara M, Kobara H, Mori H, Okano K, Suzuki Y, Himoto T, Masaki T. Samukawa E, et al. Among authors: nakahara m. Int J Oncol. 2017 Dec;51(6):1674-1684. doi: 10.3892/ijo.2017.4177. Epub 2017 Oct 23. Int J Oncol. 2017. PMID: 29075786 Free PMC article.
Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients.
Fujita K, Mimura S, Iwama H, Nakahara M, Oura K, Tadokoro T, Nomura T, Tani J, Yoneyama H, Morishita A, Oryu M, Himoto T, Nishitsuji H, Shimotohno K, Omata M, Masaki T. Fujita K, et al. Among authors: nakahara m. Int J Mol Sci. 2018 Jul 2;19(7):1940. doi: 10.3390/ijms19071940. Int J Mol Sci. 2018. PMID: 30004437 Free PMC article. Clinical Trial.
Serum microRNA-125a-5p as a potential biomarker of HCV-associated hepatocellular carcinoma.
Oura K, Fujita K, Morishita A, Iwama H, Nakahara M, Tadokoro T, Sakamoto T, Nomura T, Yoneyama H, Mimura S, Tani J, Kobara H, Okano K, Suzuki Y, Masaki T. Oura K, et al. Among authors: nakahara m. Oncol Lett. 2019 Jul;18(1):882-890. doi: 10.3892/ol.2019.10385. Epub 2019 May 21. Oncol Lett. 2019. PMID: 31289566 Free PMC article.
Efficacy of combined modality therapy with sorafenib following hepatic arterial injection chemotherapy and three-dimensional conformal radiotherapy for advanced hepatocellular carcinoma with major vascular invasion.
Nomura T, Tani J, Deguchi A, Nakahara M, Oura K, Tadokoro T, Fujita K, Mimura S, Sakamoto T, Morishita A, Yoneyama H, Kobara H, Sanomura T, Nishiyama Y, Okano K, Suzuki Y, Takahashi S, Shibata T, Tsutsui K, Himoto T, Masaki T. Nomura T, et al. Among authors: nakahara m. Mol Clin Oncol. 2019 Nov;11(5):447-454. doi: 10.3892/mco.2019.1920. Epub 2019 Sep 9. Mol Clin Oncol. 2019. PMID: 31602300 Free PMC article.
Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct-acting antiviral treatment: All Kagawa Liver Disease Group Study.
Tani J, Morishita A, Sakamoto T, Takuma K, Nakahara M, Fujita K, Oura K, Tadokoro T, Mimura S, Nomura T, Yoneyama H, Kobara H, Himoto T, Tsutsui A, Senoh T, Nagano T, Ogawa C, Moriya A, Deguchi A, Takaguchi K, Masaki T. Tani J, et al. Among authors: nakahara m. Oncol Lett. 2020 Mar;19(3):2205-2212. doi: 10.3892/ol.2020.11341. Epub 2020 Jan 23. Oncol Lett. 2020. PMID: 32194718 Free PMC article.
Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis.
Shi T, Fujita K, Gong J, Nakahara M, Iwama H, Liu S, Yoneyama H, Morishita A, Nomura T, Tani J, Takuma K, Tadokoro T, Himoto T, Oura K, Tsutsui K, Kobara H, Masaki T. Shi T, et al. Among authors: nakahara m. Oncol Rep. 2020 Aug;44(2):457-468. doi: 10.3892/or.2020.7630. Epub 2020 May 29. Oncol Rep. 2020. PMID: 32627038 Free PMC article.
Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma.
Kohno T, Morishita A, Iwama H, Fujita K, Tani J, Takuma K, Nakahara M, Oura K, Tadokoro T, Nomura T, Yoneyama H, Kato K, Okano K, Suzuki Y, Nishiyama A, Himoto T, Masaki T. Kohno T, et al. Among authors: nakahara m. Oncol Lett. 2020 Aug;20(2):1727-1733. doi: 10.3892/ol.2020.11696. Epub 2020 Jun 5. Oncol Lett. 2020. PMID: 32724415 Free PMC article.
643 results